Basit öğe kaydını göster

High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer

dc.contributor.authorSavas, I
dc.contributor.authorKose, K
dc.contributor.authorKurtman, C
dc.contributor.authorGonullu, U
dc.contributor.authorErdogan, S
dc.contributor.authorCelebioglu, B
dc.contributor.authorGurkan, OU
dc.date.accessioned2021-03-05T16:05:59Z
dc.date.available2021-03-05T16:05:59Z
dc.date.issued2002
dc.identifier.citationCelebioglu B., Gurkan O., Erdogan S., Savas I., Kose K., Kurtman C., Gonullu U., "High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer", JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.32, ss.443-448, 2002
dc.identifier.issn0368-2811
dc.identifier.othervv_1032021
dc.identifier.otherav_bf014dfb-c824-42fd-88ea-6b4f143b194b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/126838
dc.identifier.urihttps://doi.org/10.1093/jjco/hyf102
dc.description.abstractBackground: Intraluminal brachytherapy has become an established treatment for major airway occlusion by relapsed or persistent inoperable endobronchial tumors. The aim of this study was to compare the palliation improvement pre- and post-radiotherapy.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.titleHigh dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer
dc.typeMakale
dc.relation.journalJAPANESE JOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume32
dc.identifier.issue11
dc.identifier.startpage443
dc.identifier.endpage448
dc.contributor.firstauthorID38064


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster